Currently in shortage
Gilead supply chain issue following US plant upgrade. PrEP patients advised to contact HIV services for alternatives.
Expected resolution: 31 August 2025
emtricitabine + tenofovir disoproxil
Truvada
200 mg/300 mg · tablet · HIV
PBS Pricing
| General patient co-payment | $31.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $624.80 |
PBS Information
- Item code
- ANV005
- Drug name
- emtricitabine + tenofovir disoproxil
- Brand name
- Truvada
- Manufacturer
- Gilead
- Formulation
- tablet
- Strength
- 200 mg/300 mg
- Max quantity
- 30 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- HIV
TGA Reference: TGA-MSI-2025-008 · Sponsor: Gilead Sciences Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.